Cargando…
Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions
Mammalian target of rapamycin (mTOR) is a key regulator of cell growth, proliferation and angiogenesis. mTOR signaling is frequently hyper activated in a broad spectrum of human cancers thereby making it a potential drug target. The current drugs available have been successful in inhibiting the mTOR...
Autores principales: | Nasr, Arash Boroumand, Ponnala, Deepika, Sagurthi, Someshwar Rao, Kattamuri, Ramesh Kumar, Marri, Vijaya Kumar, Gudala, Suresh, Lakkaraju, Chandana, Bandaru, Srinivas, Nayarisseri, Anuraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512006/ https://www.ncbi.nlm.nih.gov/pubmed/26229292 http://dx.doi.org/10.6026/97320630011307 |
Ejemplares similares
-
Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist
por: Bandaru, Srinivas, et al.
Publicado: (2014) -
Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin–Tacrine hybrids against Acetyl Choline Esterase
por: Babitha, Pallikkara Pulikkal, et al.
Publicado: (2015) -
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
por: Sahila, Mohammed Marunnan, et al.
Publicado: (2015) -
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
por: Sinha, Chanda, et al.
Publicado: (2014) -
Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor
por: Akare, Uday Raj, et al.
Publicado: (2014)